Energy balance
AMPK activation improves insulin sensitivity and prevents type-2 diabetes by inhibiting lipogenesis and activating fatty acid oxidation, thereby reducing the inflammatory and metabolic stress associated with insulin resistance.
To support metabolic health, focus on strategies that naturally activate AMPK, such as regular physical activity and calorie restriction. These actions help inhibit fat synthesis and promote fat burning, which can improve how your body responds to insulin. While specific drugs like metformin target this pathway, lifestyle changes that mimic this activation (exercise, managing nutrient intake) are the foundational approach for preventing insulin resistance.
AMPK activation improves insulin sensitivity by inhibiting lipogenesis (ACC1, SREBP1c), protein synthesis (mTORC1) and lipolysis (HSL), and by activating FAO (ACC2). These pathways are associated with reduced inhibitory phosphorylation of IRS-1/2, ER stress/ROS, FFAs and chronic inflammation.
Why this rating
The paper is a comprehensive review citing multiple studies on molecular mechanisms and clinical drug effects (metformin).
Source
Regulation and function of AMPK in physiology and diseases
Sang‐Min Jeon · Experimental & Molecular Medicine · 2016
DOI 10.1038/emm.2016.81
More from this paper
- AMPK activation prevents cancer initiation and promotion by suppressing chronic inflammation and anabolic pathways, but may promote progression and metastasis in established tumors by enabling metabolic adaptation.Good
- Chronic inflammation and obesity suppress AMPK activity, creating a negative feedback loop that exacerbates insulin resistance and metabolic disease.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →